Illumina, Inc. (ILMN)
209.55
-3.38
(-1.59%)
USD |
NASDAQ |
Nov 12, 16:00
209.60
+0.05
(+0.02%)
Pre-Market: 08:15
Illumina Enterprise Value : 32.83B for Nov. 12, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 32.83B |
| November 11, 2026 | 33.34B |
| November 10, 2026 | 33.64B |
| November 09, 2026 | 34.53B |
| November 06, 2026 | 33.37B |
| November 05, 2026 | 32.59B |
| November 04, 2026 | 35.41B |
| November 03, 2026 | 37.18B |
| November 02, 2026 | 35.42B |
| October 30, 2026 | 36.85B |
| October 29, 2026 | 45.07B |
| October 28, 2026 | 44.87B |
| October 27, 2026 | 43.46B |
| October 26, 2026 | 42.17B |
| October 23, 2026 | 41.93B |
| October 22, 2026 | 41.92B |
| October 21, 2026 | 43.97B |
| October 20, 2026 | 41.70B |
| October 19, 2026 | 40.90B |
| October 16, 2026 | 40.88B |
| October 15, 2026 | 41.70B |
| October 14, 2026 | 42.28B |
| October 13, 2026 | 42.19B |
| October 12, 2026 | 43.03B |
| October 09, 2026 | 43.26B |
| Date | Value |
|---|---|
| October 08, 2026 | 41.19B |
| October 07, 2026 | 41.68B |
| October 06, 2026 | 42.55B |
| October 05, 2026 | 45.62B |
| October 02, 2026 | 42.48B |
| October 01, 2026 | 41.37B |
| September 30, 2026 | 42.58B |
| September 29, 2026 | 42.43B |
| September 28, 2026 | 42.42B |
| September 25, 2026 | 42.13B |
| September 24, 2026 | 42.72B |
| September 23, 2026 | 39.92B |
| September 22, 2026 | 38.73B |
| September 21, 2026 | 37.42B |
| September 18, 2026 | 37.54B |
| September 17, 2026 | 38.38B |
| September 16, 2026 | 35.93B |
| September 15, 2026 | 34.92B |
| September 14, 2026 | 32.80B |
| September 11, 2026 | 32.53B |
| September 10, 2026 | 31.75B |
| September 09, 2026 | 32.31B |
| September 08, 2026 | 33.23B |
| September 04, 2026 | 34.31B |
| September 03, 2026 | 34.83B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agilent Technologies, Inc. | 50.97B |
| Thermo Fisher Scientific, Inc. | 294.59B |
| QIAGEN NV | 11.16B |
| Pacific Biosciences of California, Inc. | 1.121B |
| Bio-Rad Laboratories, Inc. | 9.660B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 220.00M |
| Revenue (Quarterly) | 1.13B |
| Total Expenses (Quarterly) | 910.00M |
| EPS Diluted (Quarterly) | 1.429 |
| Gross Profit Margin (Quarterly) | 73.54% |
| Profit Margin (Quarterly) | 19.47% |
| Earnings Yield | 2.78% |
| Operating Earnings Yield | 2.92% |
| Normalized Earnings Yield | 2.43 |